DUPILUMAB SIGNIFICANTLY IMPROVES CLINICAL EFFICACY IN PEDIATRIC ATOPIC DERMATITIS PATIENTS <12 YEARS OF AGE

被引：0
|
作者：
Katelaris, Constance [1 ,2 ]
Baselga, Eulalia [3 ]
Ramien, Michele [4 ,5 ]
Marcoux, Danielle [6 ,7 ]
de Graaf, Marlies [8 ]
Irvine, Alan [9 ]
Carvalho, Vania Oliveira [10 ]
Ardusso, Ledit R. F. [11 ]
Toledo-Bahena, Mirna [12 ]
Gupta, Rajan [13 ]
Tong, Thu [14 ]
Zhang, Annie [13 ]
机构：
[1] Campbelltown Hosp, Campbelltown, Australia
[2] Western Sydney Univ, Sydney, Australia
[3] Hosp St Joan Deu, Barcelona, Spain
[4] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada
[5] Univ Calgary, Calgary, AB, Canada
[6] Univ Montreal, Montreal, PQ, Canada
[7] CHU St Justine Univ Hosp Ctr, Montreal, PQ, Canada
[8] Univ Med Ctr Utrecht, Utrecht, Netherlands
[9] Trinity Coll Dublin, Dublin, Ireland
[10] Univ Fed Parana, Hosp Clin, Curitiba, Brazil
[11] Natl Univ Rosario, Sch Med, Rosario, Argentina
[12] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, Mexico
[13] Sanofi, Cambridge, MA USA
[14] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
10.1111/imj.81_16230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P82
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] Dupilumab rapidly improves atopic dermatitis symptoms in children aged ≥ 6 to < 12 years as measured by POEM
    Silverberg, J. I.
    Eichenfield, L. F.
    Wollenberg, A.
    Praestgaard, A.
    Delevry, D.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E119 - E119
  • [2] DUPILUMAB RAPIDLY IMPROVES ATOPIC DERMATITIS SYMPTOMS IN CHILDREN AGED ≥ 6 TO<12 YEARS AS MEASURED BY POEM
    Wollenberg, Andreas
    Paller, Amy S.
    Silverberg, Jonathan I.
    Eichenfield, Lawrence F.
    Praestgaard, Amy
    Delevry, Dimittri
    Rossi, Ana B.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 59 - 60
  • [3] Dupilumab in children aged ≥6 to <12 years significantly improves severe atopic dermatitis: results from phase 3 trial (LIBERTY AD PEDS)
    Gooderham, M.
    Boguniewicz, M.
    Sher, L.
    Weisman, J.
    Bansal, A.
    Staudinger, H. W.
    Worrell, R.
    Patel, N.
    Graham, N. M. H.
    Ruddy, M.
    Sun, X.
    Beazley, B.
    Shumel, B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 59 - 60
  • [4] The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
    Kamal, Mohamed A.
    Kovalenko, Pavel
    Kosloski, Matthew P.
    Srinivasan, Kamal
    Zhang, Yi
    Rajadhyaksha, Manoj
    Lai, Ching-Ha
    Kanamaluru, Vanaja
    Xu, Christine
    Sun, Xian
    Simpson, Eric L.
    Paller, Amy S.
    Siegfried, Elaine C.
    Shumel, Brad
    Bansal, Ashish
    Al-Huniti, Nidal
    Davis, John D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1318 - 1328
  • [5] 5 Years of Dupilumab for Patients with atopic Dermatitis
    不详
    DERMATOLOGIE IN BERUF UND UMWELT, 2023, 71 (01) : 42 - 42
  • [6] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
    Berdyshev, Evgeny
    Goleva, Elena
    Bissonnette, Robert
    Bronova, Irina
    Bronoff, Anna Sofia
    Richers, Brittany N.
    Garcia, Shannon
    Ramirez-Gama, Marco
    Taylor, Patricia
    Praestgaard, Amy
    Agueusop, Inoncent
    Jurvilliers, Pauline
    Boguniewicz, Mark
    Levit, Noah A.
    Rossi, Ana B.
    Zhang, Annie
    Leung, Donald Y. M.
    ALLERGY, 2022, 77 (11) : 3388 - 3397
  • [7] Dupilumab treatment improves health-related quality of life in children aged ≥6 to <12 years with severe atopic dermatitis
    Irvine, Alan
    Deleuran, Mette
    Praestgaard, Amy
    Delevry, Dimittri
    Prescilla, Randy
    Rossi, Ana B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB144 - AB144
  • [8] Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials
    Beck, L. A.
    Silverberg, J. I.
    Simpson, E. L.
    Yosipovitch, G.
    Eckert, L.
    Guillemin, I.
    Chen, Z.
    Ardeleanu, M.
    Plaum, S.
    Graham, N.
    Ruddy, M.
    Pirozzi, G.
    Gadkari, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) : E130 - E133
  • [9] Dupilumab treatment improves health-related quality of life in children aged ≥ 6 to < 12 years with severe atopic dermatitis
    Irvine, A. D.
    Deleuran, M.
    Praestgaard, A.
    Delevry, D.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E71 - E71
  • [10] Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis
    Kamal, Mohamed A.
    Kosloski, Matthew P.
    Lai, Ching-Ha
    Partridge, Michael A.
    Rajadhyaksha, Manoj
    Kanamaluru, Vanaja
    Bansal, Ashish
    Shabbir, Arsalan
    Shumel, Brad
    Ardeleanu, Marius
    Richards, Susan M.
    Yan, Hong
    Xu, Christine R.
    Rodriguez-Marco, Ainara
    Xiao, Jing
    Khokhar, Faisal A.
    Gherardi, Guy
    Babilonia, Elisa
    Maloney, Jennifer
    Mortensen, Eric
    Akinlade, Bolanle
    Braunstein, Ned
    Stahl, Neil
    Torri, Albert
    Davis, John D.
    Dicioccio, A. Thomas
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345